Works matching IS 03065251 AND DT 1991 AND VI 32 AND IP 6
1
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 669, doi. 10.1111/j.1365-2125.1991.tb03971.x
- Article
2
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 755, doi. 10.1111/j.1365-2125.1991.tb03985.x
- Carboni, GP;
- Scardovi, AB;
- D'Ermo, M;
- Prati, PL
- Article
3
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 713, doi. 10.1111/j.1365-2125.1991.tb03978.x
- Article
4
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 768, doi. 10.1111/j.1365-2125.1991.tb03989.x
- Herd, B;
- Wynne, H;
- Wright, P;
- James, O;
- Woodhouse, K
- Article
5
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 775, doi. 10.1111/j.1365-2125.1991.tb03991.x
- McNeil, JJ;
- Drummer, OH;
- Raymond, K;
- Conway, EL;
- Louis, WJ
- Article
6
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 723, doi. 10.1111/j.1365-2125.1991.tb03980.x
- Baak, MA;
- Koene, FM;
- Verstappen, FT;
- Tan, ES
- Article
7
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 735, doi. 10.1111/j.1365-2125.1991.tb03982.x
- Smith, DA;
- Chandler, MH;
- Shedlofsky, SI;
- Wedlund, PJ;
- Blouin, RA
- Article
8
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 691, doi. 10.1111/j.1365-2125.1991.tb03975.x
- Waller, DG;
- Roseveare, C;
- Renwick, AG;
- Macklin, B;
- George, CF
- Article
9
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 758, doi. 10.1111/j.1365-2125.1991.tb03986.x
- Woolfson, RG;
- Benjamin, N;
- Todd, SD;
- Poston, L;
- Ritter, JM
- Article
10
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 717, doi. 10.1111/j.1365-2125.1991.tb03979.x
- Young, IS;
- Goh, EM;
- McKillop, UH;
- Stanford, CF;
- Nicholls, DP;
- Trimble, ER
- Article
11
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 729, doi. 10.1111/j.1365-2125.1991.tb03981.x
- Tinel, M;
- Berson, A;
- Pessayre, D;
- Letteron, P;
- Cattoni, MP;
- Horsmans, Y;
- Larrey, D
- Article
12
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 685, doi. 10.1111/j.1365-2125.1991.tb03974.x
- Stacher, G;
- Bergmann, H;
- Granser-Vacariu, GV;
- Wiesnagrotzki, S;
- Wenzelabatzi, TA;
- Gaupmann, G;
- Kugi, A;
- Steinringer, H;
- Schneider, C;
- Hobart, J
- Article
13
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 677, doi. 10.1111/j.1365-2125.1991.tb03973.x
- Isah, AO;
- Rawlins, MD;
- Bateman, DN
- Article
14
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 751, doi. 10.1111/j.1365-2125.1991.tb03984.x
- Lebedevs, TH;
- Wojnar-Horton, RE;
- Yapp, P;
- Roberts, MJ;
- Dusci, LJ;
- Hackett, LP;
- Ilett, KF
- Article
15
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 705, doi. 10.1111/j.1365-2125.1991.tb03977.x
- Thomas, SH;
- Clark, KL;
- Allen, R;
- Smith, SE
- Article
16
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 765, doi. 10.1111/j.1365-2125.1991.tb03988.x
- Osborne, NJ;
- Tonkin, AL;
- Miners, JO
- Article
17
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 771, doi. 10.1111/j.1365-2125.1991.tb03990.x
- Waller, DG;
- Usman, F;
- Renwick, AG;
- Macklin, B;
- George, CF
- Article
18
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 671, doi. 10.1111/j.1365-2125.1991.tb03972.x
- Article
19
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 741, doi. 10.1111/j.1365-2125.1991.tb03983.x
- Pirmohamed, M;
- Graham, A;
- Roberts, P;
- Smith, D;
- Chadwick, D;
- Breckenridge, AM;
- Park, BK
- Article
20
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 697, doi. 10.1111/j.1365-2125.1991.tb03976.x
- Soons, PA;
- Boer, A;
- Cohen, AF;
- Breimer, DD
- Article
21
- British Journal of Clinical Pharmacology, 1991, v. 32, n. 6, p. 761, doi. 10.1111/j.1365-2125.1991.tb03987.x
- Shah, J;
- Teitelbaum, P;
- Molony, B;
- Gabuzda, T;
- Massey, I
- Article